抑制剂:
α2-Macroglobulin, AMAP-1, AMID, Aminopeptidase B, Aminopeptidase B-L1, Aminopeptidase P, Aminopeptidase P2, Aminopeptidase P3, aminopeptidase-I, AMZ1, Angiotensinase C, Antipain dihydrochloride, BC048546, BLM hydrolase, carboxypeptidase B2 (TAFI), CCP2, CD13, CLPSL1, CNDP2, CPA1, CPA4, CPD, CPVL, Dispase I, DPEP1, DPEP3, ERAP1, ERAP2, FIBCD1, granzyme H, granzyme M, HKIB9, Klkb21, laeverin_4833403I15Rik, LAP3, Leukotriene A4 hydrolase, LMLN, LOC150935, Lysozyme C, MUP2, MUP4, murinoglobulin 2, NAALAD2, neuroserpin, NPEPL1, NYNRIN, ORAOV1, OTTMUSG00000013284, OTTMUSG00000014862, OTTMUSG00000015173, OTTMUSG00000015220, OTTMUSG00000015279, OTTMUSG00000015337, OTTMUSG00000015417, OTTMUSG00000015643, OTTMUSG00000015752, OTTMUSG00000016293, P-Rex2, PDP2, PEPD, PGPEP1L, Polyserase-1, PRB2, PRB3, prochymosin, Pronase, PRSS33, RNF175, SCGB1D4, SerpinB1b, SLC15A solute carrier (SLC) group, Spi11, SUMO-2, TESP3, TLCK, TMEM169, TPCK, TRIM50, V3R 2, VibH, ZFP30, 和 ZP4.